期刊文献+

阿魏酸川芎醇酯对氧化损伤内皮细胞ICAM-1表达的影响 被引量:2

Influence of 2(4-hydroxy-3-methoxycinnamon acyloxymethyl)-3,5,6-trimethylpyrazine on Expression of ICAM-1 in Endothelial Cells Injured by Hydrogen Peroxide
下载PDF
导出
摘要 目的观察川芎嗪衍生物阿魏酸川芎醇酯(TMPF)对H2O2引起的脐静脉内皮细胞(ECV304)氧化性损伤的保护作用,并初步探讨其作用机制。方法以H2O2损伤ECV304细胞建立氧化损伤模型,以川芎嗪(TMP)作为阳性对照药物,观察TMPF对氧化损伤的ECV304细胞的保护作用[按试剂盒说明测量微量丙二醛(MDA)含量及超氧化物歧化酶(SOD)活力;采用Real-Time PCR测定ICAM-1mRNA含量;采用Elisa检测ICAM-1蛋白表达]。结果与正常对照组比较,H2O2损伤组细胞内的MDA含量明显升高(P<0.01),TMP与TMPF各浓度保护组MDA含量明显低于H2O2损伤组(P<0.05或P<0.01),且TMPF保护组MDA含量均低于同剂量TMP保护组(P<0.05);与正常对照组比较,H2O2损伤组细胞内的SOD水平明显降低(P<0.05或P<0.01),在12.5μmol.L-1 TMP保护组和TMPF保护组与H2O2损伤组相比差异无统计学意义(P>0.05),在TMP和TMPF的其他浓度上与H2O2损伤组相比差异均有统计学意义(P<0.05或P<0.01)。H2O2可上调ICAM-1mRNA的含量,正常对照组ICAM-1mRNA的含量为H2O2损伤组的0.245倍,25.0μmol.L-1 TMP保护组ICAM-1mRNA的含量为H2O2损伤组的0.454倍,25.0μmol.L-1 TMPF保护组ICAM-1mRNA的含量为H2O2损伤组的0.376倍。H2O2损伤组细胞ICAM-1蛋白的表达量显著高于正常对照组(P<0.01),25.0μmol.L-1 TMP保护组ICAM-1蛋白的表达量低于H2O2损伤组(P<0.05),而25.0μmol.L-1 TMPF保护组ICAM-1蛋白的表达量显著低于H2O2损伤组(P<0.01)。结论 TMPF对H2O2引起内皮细胞氧化性损伤有明显的保护作用,能减少内皮细胞脂质过氧化物MDA的生成,提高SOD活性,TMPF能降低损伤细胞ICAM-1mRNA的含量及其蛋白表达。TMPF对氧化损伤内皮细胞中ICAM-1表达上调有较强的抑制作用,这可能是TMPF对内皮细胞氧化损伤保护作用的重要机制。 Objective To investigate the protective effect of 2-(4-hydroxy-3-methoxycinnamon acyloxymethyl)-3,5,6-trimethylpyrazine(TMPF)on oxidative damage in human umbilical vein endothelial cells(ECV304),and to explore the mechanism of TMPF action.Methods The ECV304 cells were damaged by hydrogen peroxide and the protective effects of TMP and TMPF on oxidative damage were observed(Determination of MDA content and SOD vitality according to kit instructions;Determination of expression of ICAM-1 by real-time PCR;Determination of the expression of ICAM-1protein by Elisa).Results Compared with normal control cells,hydrogen peroxide induced an increased in malondialdehyde(MDA) content and a decrease in superoxide dismutase(SOD) activity(P0.05or P0.01).However,TMP or TMPF treatment sifnificantly inhibited hydrogen peroxide-induced MDA formation and increased SOD activity(P0.05or P0.01).Compared TMP treatment,TMPF treatment reduced MDA formation and elevated SOD activity.But no significant reduction in SOD activity was obtained by treatment with TMP or TMPF at dose of 12.5 μ mol.L-1(P0.05).The expression of ICAM-1mRNA in normal control group,25.0 μ mol.L-1 TMP treatment group and 25.0 μ mol.L-1 TMPF treatment group was 0.245,0.454 and 0.376 times higher than that in hydrogen peroxide treatment group,respectively.Compared with hydrogen peroxide treatment group,the expression of ICAM-1protein significantly decreased in normal control group,25.0 μ mol.L-1 TMP treatment group and 25.0 μ mol.L-1 TMPF treatment group(P0.05or P0.01).Conclusion TMPF can protect hydrogen peroxide-induced oxidative damage,decrease MDA formation and increased SOD activity.TMPF may reduce ICAM1expression to attenuate oxidative damage in endothelial cells.
作者 丁倩 王守训
出处 《南昌大学学报(医学版)》 CAS 2012年第4期26-30,共5页 Journal of Nanchang University:Medical Sciences
关键词 川芎嗪衍生物 内皮细胞 氧化损伤 动脉粥样硬化 tetramethylpyrazine derivatives endothelial cells oxidative damage atherosclerosis
  • 相关文献

参考文献7

二级参考文献63

共引文献35

同被引文献18

  • 1赵慧娟,龙明智.心肌缺血再灌注损伤机制的研究近况[J].中西医结合心脑血管病杂志,2005,3(3):240-242. 被引量:12
  • 2Libby P, Ridker P M, Hansson G K. Inflammation in atheroscle- rosis: from pathophysiology to practice [ J ]. J Am Coll Cardiol, 2009, 54(23) :2129.
  • 3Boyle J J. Association of coronary plaque rupture and atheroscle- rotic inflammation[J]. J Pathol, 1997, 181(1) :93.
  • 4Devaraj S, Rogers J, Jialal I. Statins and biomarkers of inflam- mation [ J ]. Curr Atheroscler Rep,2007, 9 ( 1 ) : 33.
  • 5Lawrence T, Gilroy D W, Colville-Nash P R, et al. Possible new role for NF-kappa B in the resolution of inflammation [ J ]. Nat Med, 2001,7:1291.
  • 6Alizadeh Dehnavi R, de Roos A, Rabelink T J, et al. Elevated CRP levels are associated with increased carotid atherosclerosis independent of visceral obesity [ J]. Atherosclerosis, 2008, 200 (2): 417.
  • 7Venugopal S K, Devaraj S, Yuhanna I, et al. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells [ J ]. Circulation, 2002, 106 (12) : 1439.
  • 8Venugopal S K, Devaraj S, Jialal I. C-reactive protein decreases prostacyclin release from human aortic endothelial cells[ J]. Cir- culation, 2003, 108 (14) : 1676.
  • 9Torzewski M, Rist C, Mortensen R F, et al. C-reactive protein in the arterial intima: role of C-reactive protein receptordependent monocyte recruitment in atherogenesis [ J ]. Arterioscler Thromb vase Biol, 2000, 20(9) :2094.
  • 10Bharadwaj D, Stein M P, Volzer M, et al. The major receptor for C-reactive protein on eukocytes is Fcy receptor II[ J ]. J Exp Med, 1999, 190(4) : 585.

引证文献2

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部